Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00131066 · ClinicalTrials.gov registry record
Long-Term Follow-Up Study of Psoriasis Patients
A clinical trial, sponsored by MedImmune.
- Completed
- Registry status
- 200
- Enrollment target
NCT00131066: Completed study, sponsored by MedImmune.
NCT00131066 is a clinical trial that has completed, run by MedImmune. The registered enrollment target is 200 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00131066 has completed, sponsored by MedImmune.
- COMPLETED
- Registry status
- 200 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the long-term safety and profile of psoriasis patients who have completed participation in a previous study and who received treatment with MEDI-507.
Interventions
- OTHER Follow up from previous treatment with MEDI-507
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2002-08 |
| Est. Completion | 2007-12 |
What the finished NCT00131066 record still lists
NCT00131066 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Follow up from previous treatment with MEDI-507 is the first listed.
NCT00131066 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00131066 about?
NCT00131066 is a clinical study titled "Long-Term Follow-Up Study of Psoriasis Patients". The purpose of this study is to evaluate the long-term safety and profile of psoriasis patients who have completed participation in a previous study and who received treatment with MEDI-507.
What is the current status of trial NCT00131066?
This trial is currently completed. The enrollment target is 200 participants. The study started on 2002-08. Estimated completion is 2007-12.
What interventions are being tested in trial NCT00131066?
The interventions under investigation include: Follow up from previous treatment with MEDI-507 (OTHER).
Who is sponsoring clinical trial NCT00131066?
This trial is sponsored by MedImmune, which has 210 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia